MJ Biotech, Inc. Entered Into Joint Venture Agreement with Drinks 24 Ltd

CHEYENNE, WY, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – MJ Biotech, Inc. MJTV (f/k/a Michael James Enterprises, Inc.) announces that MJ Biotech, Inc. has entered into Joint Venture Agreement with Drinks 24 Ltd, one of Europe's largest exporters of bottled water. The Joint Venture Agreement gives MJ Biotech Inc. the exclusive distribution rights in Canada, Mexico and the United States.   MJ Biotech, Inc will be introducing Natural Mineral Water bottle as part of our health and wellness program initially across the United States, then Canada and Mexico.

Bottled water is the No. 1 beverage in the United States, by volume. In 2017, bottled water volume grew to 13.7 billion gallons, a 7 percent increase over the previous year. Bottled water sales now total $18.5 billion, an increase of 8.8 percent. Per capita consumption saw a 6.2 percent increase from last year, exceeding over 42 gallons of bottled water. According to the industry experts, a large part of the sales growth for bottled water is a result of a "consumer shift" from sugar-sweetened beverages to bottled water. Worldwide projected revenue in the Bottled Water segment amounts to US $40,447m in 2018. The market is expected to grow annually by 4.7% (CAGR 2018-2021).

About Drinks 24 Ltd

Drinks 24 Ltd, headquartered in Bulgaria, is a major exporter of Natural Mineral Water and a variety of distilled spirits. The Company is seeking to expand its operations not only in North America through its Joint Venture Agreement with MJ Biotech, Inc., but also in the Middle East and Asia-Pacific Region.

About MJ Biotech, Inc.

With a mission and commitment to promote health and wellness, MJ Biotech, Inc. is diligently seeking new Commercial opportunities and relationships.  These exciting new avenues range from the Medical Cannabis sector to healthy lifestyle products. 

It is the goal at MJ Biotech, Inc. to not only promote and provide products for the public good, but to always remember our prime directive is that of enhancing Shareholder value. 

We believe we can achieve both of these objectives by promoting positive lifestyle choices in the Commercial relationships that we create, foster and support. 

Safe Harbor Statement

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether because of new information, future events or any other reason.

For additional information please contact via email at info@mjbiotech.us